An equine herpesvirus 1 (EHV-1) vectored H1 vaccine protects against challenge with swine-origin influenza virus H1N1

Veterinary Microbiology

Volumn 154, Issue 1-2, 2011, Pages 113-123

  Said, Abdelrahman ^a   Damiani, Armando ^a   Ma, Guanggang ^a   Kalthoff, Donata ^b   Beer, Martin ^b   Osterrieder, Nikolaus ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

EHV 1; S OIV H1N1; Vector vaccine

Indexed keywords

HEMAGGLUTININ; HERPES VACCINE; HERPESVIRUS VECTOR; RECOMBINANT PROTEIN; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EQUINE ABORTION HERPETOVIRUS; EQUINE HERPES VIRUS; IMMUNOFLUORESCENCE; IN VITRO STUDY; INFLUENZA; INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SWINE INFLUENZA VIRUS; VIRAL CLEARANCE; VIRUS ISOLATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; FEMALE; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HERPESVIRUS 1, EQUID; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; RECOMBINANT PROTEINS;

ANIMALIA; EQUID HERPESVIRUS 1; INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 80655127788     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.07.003     Document Type: Article

References (48)

1. Allen G.P., Bryans J.T. Molecular epizootiology, pathogenesis and prophylaxis of equine herpesvirus-1 infections, Progress in Vet. Microbiol. Immunol. 1986, 2:78-144.
2. Azizul H., Didier H., Lloyd H., Kasper Confronting Potential Influenza A (H5N1) pandemic with better vaccines. Emerg. Infect. Dis. 2007, 13. (10).
3. Bao L., Xu L., Zhan L., Deng W., Zhu H., Gao H., Sun H., Ma C., Lv Q., Li F., Chenb H., Zhanga L., Qin C. Challenge and polymorphism analysis of the novel A (H1N1) influenza virus to normal animals. Virus Res. 2010, 151:60-65.
4. Bot A., Antohi S., Bot S., Garcia-Sastre A., Bona C. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. Int. Immunol. 1997, 9:1641-1650.
5. Bublot M., Pritchard N., Swayne D.E., Selleck P., Karaca K., Suarez D.L., Audonnet J.C., Mickle T. Development and use of fowl pox vectored vaccines for avian influenza. Ann. N.Y. Acad. Sci. 2006, 1081:193-201.
6. Chang L.Y., Shih S.R., Shao P.L., Huang D.T., Huang L.M. Novel swine-origin influenza virus A (H1N1). The first pandemic of the 21st century. J. Formos. Med. Assoc. 2009, 108:526-532.
7. Couch R.B., Kasel J.A. Immunity to influenza in man. Annu. Rev. Microbiol. 1983, 37:529-549.
8. Daesub S., Bokyu K., Chulseung L., Kwonil J., Gunwoo H., Dongseok K., Dongseok K., Seongjun P., Bongkyun P., Jinsik O. Transmission of avian influenza virus (H3N2) to dogs. Emerg. Infect. Dis. 2008, 4(5).
9. Deck R.R., DeWitt C.M., Donnelly J.J., Liu M.A., Ulmer J.B. Characterization of humoral immune responses induced by an influenza haemagglutinin. DNA Vaccine 1997, 15:71-78.
10. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Wendy M., Xu S.X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., Graaf M.D., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., López-Gatell H., Olivera H., López I., Myers C.A., Faix D., Blair P.J., Yu C., Keene k.M., Dotson P.D., Boxrud D., Sambol A.R., Abid S.H., George K.S., Bannerman T., Moore A., Stringer l., Blevins D.J., Demmler-Harrison P., Ginsberg G.J., Kriner M., Waterman P., Smole S., Guevara S., Belongia H.F., Clark E.A., Beatrice P.A., Donis S.T., Katz R., Finelli J., Bridges L., Shaw C.B., Jernigan M., Uyeki D.B., Smith T.M., Klimov D.J., Co A.I.N.J. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201. (5937).
11. Hoffmann B., Beer M., Reid S.M., Mertens P., Oura C.A.L., Rijn van P.A., Slomka M.J., Banks J., Brown I.H., Alexander D.J., King D.P. Review of RT-PCR technologies used in veterinary virology and disease control: Sensitive and specific diagnosis of five livestock diseases notifiable to the World Organisation for Animal Health. Vet. Microbiol. 2009, 139:1-23.
12. Hoffmann B., Harder T., Lange E., Kalthoff D., Reimann I., Grund C., Oehme R., Vahlenkamp T.W., Beer M. New real-time reverse transcriptase polymerase chain reactions facilitate detection and differentiation of novel A/H1N1 influenza virus in porcine and human samples. Berl. Munch. Tierarztl. Wochenschr. 2010, 23(7-8):286-292.
13. Hubert P.H., Birkenmaier S., Rziha H.J., Osterrieder N. Alterations in the equine herpesvirus type-1 (EHV-1) strain RacH during attenuation. Zentralbl. Veterinarmed. 1996, 43:1-14.
14. Karaca K., Dubovi E.J., Siger L., Robles A., Audonnet J.C., Jiansheng Y., Jiansheng Y., Nordgren R., Minke J.M. Evaluation of the ability of canarypox-vectored equine influenza virus vaccines to induce humoral immune responses against canine influenza viruses in dogs. Am. J. Vet. Res. 2007, 68(2):208-212.
15. Karasin A.I., Schutten M.M., Cooper L.A., Smith C.B., Subbarao K., Anderson G.A., Carman S., Olsen C.W. Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: evidence for wholly human and reassortant virus genotypes. Virus Res. 2000, 68:71-85.
16. Kalthoff D., Grund C., Harder T.C., lange E., Vahlenkamp T.W., Mettenleiter T.C., Beer M. Limited susceptibility of chickens, turkeys, and mice to pandemic (H1N1) 2009 Virus. Emerg. Infect. Dis. 2010, 16(4):703-705.
17. Larsen D.L., Karasin A., Olsen C.W. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting. Vaccine 2001, 19(20-22):2842-2853.
18. Matthias G., Timm C., Harder, Jens P., Teifke, Robert K., Vahlenkamp T.W. Experimental infection and natural contact exposure of dogs with avian influenza virus (H5N1). Emerg. Infect. Dis. 2008, 14:2.
19. Michaelis M., Doerr H.W., Cinatl J. Novel swine-origin infl{ligature}uenza A virusin humans. another pandemic knocking at the door. Med. Microbiol. Immunol. 2009, 198:175-183.
20. Minke J.M., Toulemonde C.E., Coupier H., Guigal P.M., Dinic S., Sindle T., Jessett D., Black L., Bublot M., Pardo M.C., Jean-Christophe A. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. Am. J. Vet. Res. 2007, 68(2):213-219.
21. Minke J.M., Toulemonde C.E., Dinic S., Cozette V., Cullinane A., Audonnet J.C. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine. J. Comp. Pathol. 2007, 137(1):76-80.
22. Neubauer A., Meindl A., Osterrieder N. Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation. Berl. Munch. Tierarztl. Wochenschr. 1999, 112:351-354.
23. Osterrieder N., Neubauer A., Brandmuller C., Kaaden O.R., O'Callaghan D.J. The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence. Virology 1996, 226(2):243-251.
24. Palese P., Shaw M.L. Orthomyxoviridae: the viruses and their replication. Fields Virology 2007, 1647-1689. Lippincott Williams & Wilkins, Philadelphia, PA. 5th ed.
25. Robinson H.L., Hunt L.A., Webster R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 1993, 11:957-960.
26. Rosas C.T., Goodman L.B., Von E.J., Osterrieder N. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?. Expert. Rev. Vaccines 2006, 5(1):119-131.
27. Rosas C.T., Konig P., Beer M., Dubovi E.J., Tischer B.K., Osterrieder N. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins. J. Gen. Virol. 2007, 88(3):748-757.
28. Rosas C.T., Tischer B.K., Perkins G.A., Wagner B., Goodman L.B., Osterrieder N. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV). Virus Res. 2007, 125(1):69-78.
29. Rosas C.T., Paessler S., Ni H., Osterrieder N. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies. Am. J. Trop. Med. Hyg. 2008, 78(1):83-92.
30. Rosas C.T., Van de Walle G.R., Metzger S.M., Loelzer K., Dubovi E.J., Kim S.G., Parrish C.R., Osterrieder N. Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza. Vaccine 2008, 26(19):2335-3234.
31. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., Lim W., Fukuda K., Cox N.J., Katz J.M. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 1999, 37:937-943.
32. Rudolph J., O'Callaghan D.J., Osterrieder N. Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). J. Vet. Med. B Infect. Dis. Vet. Public Health 2002, 49:31-36.
33. Rudolph J., Osterrieder N. Equine herpesvirus type 1 devoid of gM and gp2 is severely impaired in virus egress but not direct cell-to-cell spread. Virology 2002, 293:356-367.
34. Sambrook J., Fritsch D.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor, New York.
35. Schild G.C., Oxford J.S., Virelizier J.L. Immunity to influenza. Dev. Biol. Stand. 1975, 28:253-272.
36. Siedek E.M., Whelan M., Edington B.N., Hamblin A. Equine herpesvirus 969 type 1 infects dendritic cells in vitro: stimulation of T lymphocyte proliferation and 970 cytotoxicity by infected dendritic cells. Vet. Immunol. Immunopathol. 1999, 67:17-32.
37. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
38. Slater J. Equine herpesviruses. Equine Infectious Disease 2007, 134-232. Saunders, St. Louis, MO.
39. Sponseller B.A., Strait E., Jergens A., Trujillo J., Harmon K., Koster L., Jenkins-Moore M., Killian M., Swenson S., Bender H., Waller K., Miles K., Pearce T., Yoon K., Nara P. Influenza a pandemic (H1N1) 2009 virus infection in domestic cat. Emerg. Infect. Dis. 2010, 16(3).
40. Steitz J., Barlow P.G., Hossain J., Kim E., Okada K., Kenniston T., Rea S., Donis R.O., Gambotto A. A candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice. PLoS ONE 2010, 5(5):10492.
41. Tischer B.K., von Einem J., Kaufer B., Osterrieder N. Two-step red-mediated recombination for versatile high-efficiency marker less DNA manipulation in Escherichia coli. Biotechnol. Tech. 2006, 40:191-197.
42. Trapp S., von Einem J., Hofmann H., Kostler J., Wild J., Wagner R., Beer M., Osterrieder N. Potential of equine herpesvirus 1 as a vector for immunization. J. Virol. 2005, 79:5445-5454.
43. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259(5102):1745-1749.
44. Vijaykrishna D., Poon L.L.M., Zhu H.C., Ma S.K., Li O.T.W., Cheung C.L., Smith G.J.D., Peiris J.S.M., Guanl Y. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 2010, 328(5985):1529.
45. Von Einem J., Wellington J., Whalley J.M., Osterrieder K., O'Callaghan D.J., Osterrieder N. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11. J. Virol. 2004, 78(6):3003-3013.
46. Wang S., Taaffe J., Parker C., Solórzano A., Cao H., García-Sastre A., Lu S. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody. J. Virol. 2006, 80(23):11628-11637.
47. Webster R.G., Fynan E.F., Santoro J.C., Robinson H. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 1994, 12(16):1495-1498.
48. World Health Organization (WHO) Manual on Animal Influenza Diagnosis and Surveillance 2010, Available at http://www.who.int/vaccine_research/diseases/influenza/WHO_manual_on_animal-diagnosis_and_surveillance_2002_5.pdf (accessed 18.09.2010).